China SXT Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Taizhou
SXTC chart
What traders are saying about $SXTC
Latest postsChina SXT Pharmaceuticals, Inc. news
- Working capital per share of China Sxt Pharmaceuticals, Inc. Class A – GETTEX:A42QHZ
TradingView ·
- China Sxt Pharmaceuticals, Inc. Class A Balance Sheet – GETTEX:A42QHZ
TradingView ·
- Reverse Stock Split Movers: Could Top Wealth Group (NASDAQ:TWG) and China SXT Pharmaceuticals (NASDAQ:SXTC) and More Keep Slipping After Share Consolidations?
kalkine.ca ·
- China SXT Pharmaceuticals (NASDAQ:SXTC) Penny Stock Sinks 11% Ahead of a 1-for-100 Consolidation: What Is Driving It?
kalkine.ca ·
- China SXT Pharmaceuticals, Inc. (SXTC) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- China SXT Pharmaceuticals To Carry Out 1-for-100 Reverse Stock Split On October 26th, 2026
Moomoo ·
- Is a 1-for-100 Share Consolidation Behind the 35% Drop Today in China SXT Pharmaceuticals (NASDAQ:SXTC) Penny Stock?
kalkine.ca ·
- China SXT Pharmaceuticals to execute 1-for-100 reverse stock split
Investing.com ·
- China SXT Pharmaceuticals announces 1-for-100 share consolidation
TradingView ·
- China SXT Pharmaceuticals, Inc. Announces Share Consolidation
Yahoo Finance ·
- China SXT Pharmaceuticals, Inc. (SXTC) Enacts 1-for-100 Reverse Split
TradingView ·
- China SXT Pharmaceuticals to consolidate shares at 1-for-100 ratio starting Oct 26, 2026
Pluang ·
China SXT Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | $1.9M | $2.0M |
| Net income | -$6.2M | -$3.3M | -$3.1M | -$5.9M |
| Diluted EPS | $-9.13 | $-348.17 | $-4285.66 | $-177.84 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 20-FANNUAL REPORT
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
About China SXT Pharmaceuticals, Inc.
- Ticker
- SXTC (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Taizhou
- Incorporated in
- Virgin Islands, British
- Fiscal year end
- March 31
- SEC CIK
- 1723980
Frequently asked questions
What exchange is China SXT Pharmaceuticals, Inc. listed on?
China SXT Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol SXTC.
What industry is China SXT Pharmaceuticals, Inc. in?
China SXT Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is China SXT Pharmaceuticals, Inc. headquartered?
China SXT Pharmaceuticals, Inc.'s business address on file with the SEC is in Taizhou.
When does China SXT Pharmaceuticals, Inc.'s fiscal year end?
China SXT Pharmaceuticals, Inc.'s fiscal year ends on March 31.
How much revenue did China SXT Pharmaceuticals, Inc. report?
China SXT Pharmaceuticals, Inc. reported $1.9M in revenue for calendar year 2023, according to its SEC filings.